๐ฐ Howard Chertkow News
Howard Chertkow News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Howard Chertkow. Real-time updates on events, politics, business and more.
April 11, 2024
Could a new model of testing and drugs make this brain disease as treatable as Type 2 diabetes? As researchers run tests to find out, neuroscience is divided on what to do for now
July 31, 2023
Katrina O'Neill, then 29, had been playing baseball when she suddenly went into cardiac arrest - leaving her on the brink of death as she was starved of oxygen for a terrifying 22 minutes
July 30, 2023
Seven years ago, Katrina OโNeil was playing baseball when she went into cardiac arrest, going nearly 22 minutes without oxygen and ending up in a three-week coma. When the 29-year-old woke up, she thought she was 15. Now, her story is being told in a new documentary.
December 3, 2022
Hope for Dementia, an organization whose mission is to safeguard healthy brains, held its second annual gala on Nov. 5 at Le Salon Crystal in St. Laurent. There were 320
June 27, 2022
/CNW Telbec/ - Canadas largest dementia research initiative, the Canadian Consortium on Neurodegeneration in Aging (CCNA), has launched an innovative online...
June 27, 2022
Canada's largest dementia research initiative, the Canadian Consortium on Neurodegeneration in Aging (CCNA), has launched an innovative online program that offers older adults the opportunity to increase their knowledge of dementia, improve lifestyle risk factors and engage with researchers.
June 27, 2022
Canadas largest dementia research initiative, the Canadian Consortium on Neurodegeneration in Aging (CCNA), has launched an innovative online program that
December 20, 2021
A group of Alzheimerโs experts and health advocates called on the F.D.A. to withdraw its approval of the drug, the latest of several setbacks for the treatment.
October 7, 2021
Aduhelm is expensive and controversial. The fact it even got approved has raised questions about the internal workings of the FDA.
October 3, 2021
The approval of a controversial new drug for Alzheimer’s disease, Aduhelm, is shining a spotlight on mild cognitive impairment.